The Influence of Warm Bupivacaine on Supraclavicular Plexus Block Characteristics

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

June 9, 2018

Study Completion Date

September 17, 2018

Conditions
Surgery to the Distal One Third of the Upper Limb
Interventions
DRUG

Warm bupivacaine at (37°c)

Bupivacaine 0.5%, 30 mL, warmed to 37◦C for 20 minutes. The empty syringes and needles, in their packaging, will be held at the same temperature before initiating the block.

DRUG

Bupivacaine at operating room temperature (23°c)

Bupivacaine 0.5%, 30 ml held in crash shelf of the operating room temperature at 23◦C. The empty syringes and needles will be held in the same temperature before use.

Trial Locations (1)

050

Mansoura University, Faculty of Medicine, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03265886 - The Influence of Warm Bupivacaine on Supraclavicular Plexus Block Characteristics | Biotech Hunter | Biotech Hunter